The Effect of Polymer Molecular Weight on Citrate Crosslinked Chitosan Films for Site-Specific Delivery of a Non-Polar Drug
AbstractPurpose: To develop citrate crosslinked chitosan films using chitosan of different molecular weights (MW) in order to achieve site-specific delivery of a model non-polar drug, indomethacin.
Methods: Films prepared with different molecular weights of chitosan and incorporating indomethacin as a non-polar model drug were obtained by a casting/solvent evaporation method. The chitosan films were crosslinked by dipping in varying concentrations of sodium citrate solution and for different crosslinking times. The films were assessed by, amongst others, scanning electron microscopy (SEM), dissolution studies and differential scanning calorimetry (DSC) for surface morphology, drug release and ingredient compatibility, respectively.
Results: Crosslinking time and concentration of crosslinking agent significantly (p < 0.05) influenced the in vitro release of indomethacin as well as swelling of the films. Also, the higher the molecular weight (MW) of chitosan the lower the drug release rate (p < 0.05). Furthermore, film swelling index rose as chitosan MW decreased (p < 0.05). The practical absence of the sharp endothermic peak characteristic of indomethacin in the films suggests that crosslinking may have transformed the drug from the crystalline to the amorphous state.
Conclusion: The citrate-crosslinked chitosan films can be modulated to vary swelling and drug release at pH 3.5 and 6.2; this feature makes them useful tools for designing site-specific delivery systems.
Keywords: Chitosan film, Sodium citrate, Site-specific delivery, Crosslinking, Indomethacin
Tropical Journal of Pharmaceutical Research December 2010; 9 (6): 525-531
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.